Rosacea subtypes: A treatment algorithm

被引:0
作者
Dahl, MV [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Dermatol, Scottsdale, AZ 85259 USA
[2] Berlex Labs Inc, Wayne, NJ 07470 USA
[3] Galderma Labs LP, Ft Worth, TX 76177 USA
[4] Johnson & Johnson, New Brunswick, NJ 08933 USA
来源
CUTIS | 2004年 / 74卷 / 03期
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Based on various signs and symptoms, the National Rosacea Society (NRS) Expert Committee has divided the syndrome of rosacea into 4 major subtypes: erythema totelangiectatic, papulopustular (inflammatory), phymatous, and ocular. Each of the subtypes can be divided further into more specific subgroups. For example, sensory rosacea is an additional subtype that can be recognized and treated. Signs and symptoms may direct therapy. This article proposes an overview of common treatments based on subtypes. Treatments that have been validated by randomized controlled trials are reviewed. However, many excellent treatments have not been validated by double-blind randomized trials.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 54 条
  • [1] EVALUATION OF TOPICAL METRONIDAZOLE GEL IN ACNE ROSACEA
    ARONSON, IK
    RUMSFIELD, JA
    WEST, DP
    ALEXANDER, J
    FISCHER, JH
    PALOUCEK, FP
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1987, 21 (04): : 346 - 351
  • [2] Tacrolimus clinical studies for atopic dermatitis and other conditions
    Bergman, J
    Rico, MJ
    [J]. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2001, 20 (04) : 250 - 259
  • [3] Bikowski J, 2001, Cutis, V68, P3
  • [4] Bjerke R, 1999, ACTA DERM-VENEREOL, V79, P456
  • [5] TOPICAL METRONIDAZOLE THERAPY FOR ROSACEA
    BLEICHER, PA
    CHARLES, JH
    SOBER, AJ
    [J]. ARCHIVES OF DERMATOLOGY, 1987, 123 (05) : 609 - 614
  • [6] BRENEMAN D, 2003, 61 ANN M AM AC DERM
  • [7] Breneman DL, 1998, CUTIS, V61, P44
  • [8] Cassuto D A, 2000, J Cutan Laser Ther, V2, P141, DOI 10.1080/14628830050516399
  • [9] Laser treatment of erythema and telangiectasia associated with rosacea
    Clark, SM
    Lanigan, SW
    Marks, R
    [J]. LASERS IN MEDICAL SCIENCE, 2002, 17 (01) : 26 - 33
  • [10] Dahl M V, 2001, Adv Dermatol, V17, P29